{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:48:28Z","timestamp":1789015708511,"version":"build-2803163510"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"crossref","award":["DEP2012-39262"],"award-info":[{"award-number":["DEP2012-39262"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"crossref","award":["SAF2011-25878"],"award-info":[{"award-number":["SAF2011-25878"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Instituto de Salud Carlos III","award":["FIS, PI11\/00315"],"award-info":[{"award-number":["FIS, PI11\/00315"]}]},{"name":"European FEDER Funds"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.phrs.2016.05.005","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T18:03:57Z","timestamp":1462385037000},"page":"102-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Circulating microRNAs in Huntington\u2019s disease: Emerging mediators in metabolic impairment"],"prefix":"10.1016","volume":"108","author":[{"given":"C.","family":"D\u00edez-Planelles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"S\u00e1nchez-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gil-Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ribacoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mart\u00ednez-Descals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mart\u00ednez-Camblor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mart\u00edn-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Huerta-Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Cosgaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Visioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"D\u00e1valos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Iglesias-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7823-0410","authenticated-orcid":false,"given":"C.","family":"Tom\u00e1s-Zapico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.05.005_bib0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s disease collaborative research group","volume":"72","author":"(HDCRG) THsDCRG","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2016.05.005_bib0010","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00018-007-7222-8","article-title":"Is the ubiquitin-proteasome system impaired in Huntington\u2019s disease","volume":"64","author":"Ortega","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.phrs.2016.05.005_bib0015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2016.05.005_bib0020","first-page":"34","article-title":"Dysfunction of wild-type huntingtin in Huntington disease","volume":"18","author":"Cattaneo","year":"2003","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.phrs.2016.05.005_bib0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI45691","article-title":"Energy deficit in Huntington disease: why it matters","volume":"121","author":"Mochel","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.05.005_bib0030","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"Mochel","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.05.005_bib0035","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher cag repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2016.05.005_bib0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/WNL.0b013e3181b04aa2","article-title":"Dietary intake in adults at risk for Huntington disease: analysis of pharos research participants","volume":"73","author":"Marder","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2016.05.005_bib0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington\u2019s disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2016.05.005_bib0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fphys.2014.00231","article-title":"Metabolic and hormonal signatures in pre-manifest and manifest Huntington\u2019s disease patients","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2016.05.005_bib0055","doi-asserted-by":"crossref","unstructured":"Identification of genetic factors that modify clinical onset of Huntington\u2019s disease, Cell 162 (2015) 516\u2013526.","DOI":"10.1016\/j.cell.2015.07.003"},{"key":"10.1016\/j.phrs.2016.05.005_bib0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2016.05.005_bib0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding rnas in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.phrs.2016.05.005_bib0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10571-013-9940-9","article-title":"Circulating micrornas: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases","volume":"33","author":"Jin","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2016.05.005_bib0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phrs.2013.02.005","article-title":"From evolution to revolution: mirnas as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport","volume":"75","author":"Davalos","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2016.05.005_bib0080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fgene.2014.00088","article-title":"Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models","volume":"5","author":"Webster","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.phrs.2016.05.005_bib0085","doi-asserted-by":"crossref","first-page":"ra81","DOI":"10.1126\/scisignal.2000610","article-title":"Delivery of microrna-126 by apoptotic bodies induces cxcl12-dependent vascular protection","volume":"2","author":"Zernecke","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.phrs.2016.05.005_bib0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"Micrornas are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2016.05.005_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2016.01.011","article-title":"Lipoprotein carriers of micrornas","author":"Michell","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2016.05.005_bib0100","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cmet.2013.06.004","article-title":"Micrornas and metabolism crosstalk in energy homeostasis","volume":"18","author":"Dumortier","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2016.05.005_bib0105","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microrna","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2016.05.005_bib0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2013.10.002","article-title":"Circulating mir-125b as a biomarker of Alzheimer\u2019s disease","volume":"336","author":"Tan","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2016.05.005_bib0115","doi-asserted-by":"crossref","first-page":"e69807","DOI":"10.1371\/journal.pone.0069807","article-title":"Circulating mirna biomarkers for Alzheimer\u2019s disease","volume":"8","author":"Kumar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.05.005_bib0120","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s00415-013-6900-8","article-title":"Profile of micrornas in the plasma of parkinson\u2019s disease patients and healthy controls","volume":"260","author":"Cardo","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.phrs.2016.05.005_bib0125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jpsychires.2011.09.010","article-title":"Aberrant expression of serum mirnas in schizophrenia","volume":"46","author":"Shi","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.phrs.2016.05.005_bib0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpsychires.2010.04.028","article-title":"Microrna-134 plasma levels before and after treatment for bipolar mania","volume":"45","author":"Rong","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.phrs.2016.05.005_bib0135","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1093\/nar\/gkq575","article-title":"A myriad of mirna variants in control and Huntington\u2019s disease brain regions detected by massively parallel sequencing","volume":"38","author":"Marti","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2016.05.005_bib0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12920-015-0083-3","article-title":"Mir-10b-5p expression in Huntington\u2019s disease brain relates to age of onset and the extent of striatal involvement","volume":"8","author":"Hoss","year":"2015","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.phrs.2016.05.005_bib0145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","article-title":"A microrna-based gene dysregulation pathway in Huntington\u2019s disease","volume":"29","author":"Johnson","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.05.005_bib0150","first-page":"8","article-title":"Microrna-22 (mir-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington\u2019s disease-related mechanisms","author":"Jovicic","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.05.005_bib0155","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","article-title":"Altered microrna regulation in Huntington\u2019s disease models","volume":"227","author":"Lee","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2016.05.005_bib0160","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/hmg\/ddr111","article-title":"Hsa-mir-34b is a plasma-stable microrna that is elevated in pre-manifest Huntington\u2019s disease","volume":"20","author":"Gaughwin","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2016.05.005_bib0165","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/mds.26457","article-title":"Study of plasma-derived mirnas mimic differences in Huntington\u2019s disease brain","volume":"30","author":"Hoss","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2016.05.005_bib0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington\u2019s disease rating scale: reliability and consistency. Huntington study group","volume":"11","author":"Group HsdS","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2016.05.005_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.29.1.1","article-title":"Huntington disease: clinical care and evaluation","volume":"29","author":"Shoulson","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2016.05.005_bib0180","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2009-10-6-r64","article-title":"A novel and universal method for microrna rt-qpcr data normalization","volume":"10","author":"Mestdagh","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.phrs.2016.05.005_bib0185","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.phrs.2016.05.005_bib0190","doi-asserted-by":"crossref","first-page":"D239","DOI":"10.1093\/nar\/gkv1258","article-title":"Mirtarbase 2016: updates to the experimentally validated mirna-target interactions database","volume":"44","author":"Chou","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2016.05.005_bib0195","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microrna target sites in mammalian mrnas","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.phrs.2016.05.005_bib0200","doi-asserted-by":"crossref","first-page":"W169","DOI":"10.1093\/nar\/gkt393","article-title":"Diana-microt web server v5.0: service integration into mirna functional analysis workflows","volume":"41","author":"Paraskevopoulou","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2016.05.005_bib0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using david bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.phrs.2016.05.005_bib0210","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1373\/clinchem.2012.195776","article-title":"Targeting the circulating microrna signature of obesity","volume":"59","author":"Ortega","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.phrs.2016.05.005_bib0215","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2337\/dc13-1847","article-title":"Profiling of circulating micrornas reveals common micrornas linked to type 2 diabetes that change with insulin sensitization","volume":"37","author":"Ortega","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.05.005_bib0220","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1177\/1352458513485654","article-title":"Decreased circulating mirna levels in patients with primary progressive multiple sclerosis","volume":"19","author":"Fenoglio","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.phrs.2016.05.005_bib0225","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3233\/JAD-140756","article-title":"Circulating mirnas as potential biomarkers in Alzheimer\u2019s disease","volume":"42","author":"Galimberti","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2016.05.005_bib0230","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the r6\/2 model of polyglutamine disease: parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2016.05.005_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004188","article-title":"Micrornas located in the hox gene clusters are implicated in Huntington\u2019s disease pathogenesis","volume":"10","author":"Hoss","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.phrs.2016.05.005_bib0240","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/bib\/bbv056","article-title":"Normalization of circulating microrna expression data obtained by quantitative real-time rt-pcr","volume":"17","author":"Marabita","year":"2015","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.phrs.2016.05.005_bib0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038946","article-title":"Profound effect of profiling platform and normalization strategy on detection of differentially expressed micrornas\u2013a comparative study","volume":"7","author":"Meyer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.05.005_bib0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024145","article-title":"Haemolysis during sample preparation alters microrna content of plasma","volume":"6","author":"Kirschner","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.05.005_bib0255","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2013.00150","article-title":"Circulating cell-free microrna as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies","volume":"7","author":"Sheinerman","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2016.05.005_bib0260","doi-asserted-by":"crossref","first-page":"925","DOI":"10.18632\/aging.100624","article-title":"Plasma microrna biomarkers for detection of mild cognitive impairment: biomarker validation study","volume":"5","author":"Sheinerman","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.phrs.2016.05.005_bib0265","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00156","article-title":"Identification of circulating micrornas for the differential diagnosis of parkinson\u2019s disease and multiple system atrophy","volume":"8","author":"Vallelunga","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2016.05.005_bib0270","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1176\/appi.ajp.2015.14030273","article-title":"Detection of circulating mirna levels in schizophrenia","volume":"172","author":"Wei","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2016.05.005_bib0275","doi-asserted-by":"crossref","DOI":"10.1186\/1756-6606-7-46","article-title":"Microrna-128a dysregulation in transgenic Huntington\u2019s disease monkeys","volume":"7","author":"Kocerha","year":"2014","journal-title":"Mol. Brain"},{"key":"10.1016\/j.phrs.2016.05.005_bib0280","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1244193","article-title":"Microrna-128 governs neuronal excitability and motor behavior in mice","volume":"342","author":"Tan","year":"2013","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.phrs.2016.05.005_bib0285","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1096\/fj.09-134965","article-title":"Mir-128 up-regulation inhibits reelin and dcx expression and reduces neuroblastoma cell motility and invasiveness","volume":"23","author":"Evangelisti","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2016.05.005_bib0290","doi-asserted-by":"crossref","first-page":"590","DOI":"10.18632\/aging.100486","article-title":"Plasma microrna biomarkers for detection of mild cognitive impairment","volume":"4","author":"Sheinerman","year":"2012","journal-title":"Aging (Albany, NY)"},{"key":"10.1016\/j.phrs.2016.05.005_bib0295","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.3980","article-title":"Genome-wide identification of micrornas regulating cholesterol and triglyceride homeostasis","volume":"21","author":"Wagschal","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.05.005_bib0300","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1093\/nar\/gkn513","article-title":"An intronic microrna silences genes that are functionally antagonistic to its host gene","volume":"36","author":"Barik","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2016.05.005_bib0305","doi-asserted-by":"crossref","first-page":"e8025","DOI":"10.1371\/journal.pone.0008025","article-title":"Formation of polyglutamine inclusions in a wide range of non-cns tissues in the hdhq150 knock-in mouse model of Huntington\u2019s disease","volume":"4","author":"Moffitt","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.05.005_bib0310","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","article-title":"Huntington\u2019s disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression","volume":"11","author":"Andreassen","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.05.005_bib0315","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","article-title":"Mice transgenic for an expanded cag repeat in the Huntington\u2019s disease gene develop diabetes","volume":"48","author":"Hurlbert","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.05.005_bib0320","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","article-title":"Evaluation of r6\/2 hd transgenic mice for therapeutic studies in Huntington\u2019s disease: behavioral testing and impact of diabetes mellitus","volume":"126","author":"Luesse","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.05.005_bib0325","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion","volume":"65","author":"Lalic","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.phrs.2016.05.005_bib0330","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1042\/CS20150235","article-title":"Circulating mir-33a and mir-33b are up-regulated in familial hypercholesterolaemia in paediatric age","volume":"129","author":"Martino","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.phrs.2016.05.005_bib0335","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1007\/s11033-014-3449-2","article-title":"Analysis of circulating micrornas that are specifically increased in hyperlipidemic and\/or hyperglycemic sera","volume":"41","author":"Simionescu","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.phrs.2016.05.005_bib0340","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.05.005_bib0345","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbalip.2014.12.018","article-title":"The impairment of cholesterol metabolism in Huntington disease","volume":"1851","author":"Leoni","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2016.05.005_bib0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146480","article-title":"A metabolic study of Huntington\u2019s disease","volume":"11","author":"Nambron","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.05.005_bib0355","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.atherosclerosis.2016.01.025","article-title":"Micrornas in lipoprotein metabolism and cardiometabolic disorders","volume":"246","author":"Rotllan","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2016.05.005_bib0360","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1172\/JCI40725","article-title":"Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver","volume":"121","author":"Onoyama","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.05.005_bib0365","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00125-013-2996-8","article-title":"Circulating mir-130b mediates metabolic crosstalk between fat and muscle in overweight\/obesity","volume":"56","author":"Wang","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.05.005_bib0370","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2265.2009.03661.x","article-title":"Leptin secretion rate increases with higher cag repeat number in Huntington\u2019s disease patients","volume":"73","author":"Aziz","year":"2010","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.phrs.2016.05.005_bib0375","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/jnnp.2009.191833","article-title":"Systemic energy homeostasis in Huntington\u2019s disease patients","volume":"81","author":"Aziz","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2016.05.005_bib0380","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-142208","article-title":"Systematic review of the relationship between amyloid-beta levels and measures of transgenic mouse cognitive deficit in Alzheimer\u2019s disease","volume":"44","author":"Foley","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2016.05.005_bib0385","doi-asserted-by":"crossref","first-page":"e57097","DOI":"10.1371\/journal.pone.0057097","article-title":"Detection of amyloid plaques targeted by bifunctional uspio in Alzheimer\u2019s disease transgenic mice using magnetic resonance microimaging","volume":"8","author":"Wadghiri","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.05.005_bib0390","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000002582","article-title":"Leisure-time physical activity associates with cognitive decline: the northern manhattan study","author":"Willey","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2016.05.005_bib0395","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1152\/japplphysiol.00077.2015","article-title":"Circulating inflammatory mirna signature in response to different doses of aerobic exercise","volume":"119","author":"de Gonzalo-Calvo","year":"2015","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.phrs.2016.05.005_bib0400","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"Mir-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2016.05.005_bib0405","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nature06783","article-title":"Lna-mediated microrna silencing in non-human primates","volume":"452","author":"Elmen","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.05.005_bib0410","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/hmg\/ddm170","article-title":"Cholesterol biosynthesis pathway is disturbed in yac128 mice and is modulated by huntingtin mutation","volume":"16","author":"Valenza","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2016.05.005_bib0415","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","article-title":"Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes","volume":"30","author":"Valenza","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.05.005_bib0420","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","article-title":"Progressive dysfunction of the cholesterol biosynthesis pathway in the r6\/2 mouse model of Huntington\u2019s disease","volume":"28","author":"Valenza","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.05.005_bib0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2016.02.002","article-title":"Exosomes as a potential novel therapeutic tools against neurodegenerative diseases","author":"Jarmalaviciute","year":"2016","journal-title":"Pharmacol. Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816304005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816304005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T05:03:51Z","timestamp":1567832631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816304005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":85,"alternative-id":["S1043661816304005"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.005","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating microRNAs in Huntington\u2019s disease: Emerging mediators in metabolic impairment","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}